A Mother’s Bravery in the Face of Metastatic Breast Cancer Taught Olympian Daughter What’s ‘Really Important in Life’

Video

Olympic volleyball player, April Ross, explained in an interview with CURE® that seeing her mother’s dedication to her family, despite her diagnosis, helped put things into perspective and taught her what is truly important in life.

April Ross was just 19 years old when her mother, Margie, died from metastatic breast cancer. Now, the U.S. beach volleyball Olympic medalist is sharing Margie’s story in the hopes that her bravery and courage will inspire others.

In an interview with CURE®, Ross explained that seeing her mother’s dedication to her family, despite her diagnosis, helped put things into perspective and taught her what is truly important in life. Ultimately, it is this drive that helped Ross secure a spot in the 2020 Tokyo Olympic Games and continues to inspire her on and off the volleyball court.

Transcription:

It's tough doing what I do. And I feel ridiculous saying that a little bit, because it's beach volleyball, but competing for a spot at the Olympics and competing at the Olympics, there's a lot of pressure and it takes a lot of dedication and sacrifice. And, you know, I think, seeing how dedicated my mom was to giving my sister and I opportunities and a normal childhood and the sacrifices she made and the courage she showed, and her bravery make it so much easier for me to draw inspiration from that and use that on the court.

You know, like, that's what my mom went through. I'm just playing beach volleyball, so I can step up and do these things on the court. So in a way, it keeps it in perspective. And like I said, it taught me what's really important in life, so it kind of eases that pressure a little bit (when) playing beach volleyball, which is really helpful.

But yeah, I think just those intrinsic things, those intangible things, you know, the spirit that she exhibited is what inspires me.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE
Dr. Giles in an interview with CURE
Related Content